$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Friday, 31'st Jan 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CHMP--BMS Receives Positive CHMP Opinion for Opdivo plus Yervoy as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced HCC.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma.
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Thursday, 30'th Jan 2025
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Bristol Myers Squibb (BMY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:07am, Thursday, 30'th Jan 2025
Bristol Myers (BMY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10 Undervalued Dividend Growth Stocks: January 2025
09:00am, Wednesday, 29'th Jan 2025
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. I use two valuation screens, one based on my fair value estimate, an
3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average
04:40am, Wednesday, 29'th Jan 2025
Many stocks don't offer particularly high yields. The stocks in the S&P 500, for instance, average a yield of just 1.3%.
Why the Market Dipped But Bristol Myers Squibb (BMY) Gained Today
06:50pm, Monday, 27'th Jan 2025
The latest trading day saw Bristol Myers Squibb (BMY) settling at $60.62, representing a +1.59% change from its previous close.
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
10:01am, Monday, 27'th Jan 2025
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ASCO--BMS Presents Results from CheckMate -8HW.
Bloomsbury inks new long-term supply deal with Amazon
03:13am, Friday, 24'th Jan 2025
Bloomsbury Publishing PLC (LSE:BMY), the home of authors such as Sarah J. Maas and J.K.
Final Trade: ET, DELL, KRE, BMY
06:31pm, Thursday, 23'rd Jan 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Top 4 Immunology Stocks Poised For Growth In 2025
04:54pm, Sunday, 19'th Jan 2025
This article will reveal an in-depth analysis of drugs being developed to combat immunological disorders. Big Pharma is keenly interested in the global immunology drugs market, which is anticipated to
Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts
06:50pm, Friday, 17'th Jan 2025
The latest trading day saw Bristol Myers Squibb (BMY) settling at $56.29, representing a -0.16% change from its previous close.
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
10:56am, Wednesday, 15'th Jan 2025
Bristol Myers Squibb believes Alzheimer's treatment is the largest potential market for its newly approved schizophrenia drug, Cobenfy, which it expects to eventually generate billions of dollars in s
Sign In
Buy BMY